Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Reexamination Certificate
2006-10-17
2006-10-17
Canella, Karen A. (Department: 1643)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
C435S252300, C435S254110, C435S325000, C514S04400A
Reexamination Certificate
active
07122343
ABSTRACT:
An isolated and purified DNA molecule encoding a DNA repair protein, p95, is provided, as is isolated and purified p95. Also provided are methods of detecting p95 and DNA encoding p95. The invention further provides p95 knock-out mice.
REFERENCES:
patent: 5965427 (1999-10-01), Dolganov et al.
patent: 6297356 (2001-10-01), DeLange et al.
patent: 6479237 (2002-11-01), Camonis et al.
patent: WO 98/07030 (1998-02-01), None
patent: WO 98/41648 (1998-09-01), None
Nockoloff and Hoekstra, DNA Damage and Repair, 1998, vol. 2, pp. 335-393.
Dolganov et al, Molecular and Cellular biology, 1996, vol. 16, pp. 4832-4841.
Verma et al (Nature, 1997, vol. 389, pp. 239-242).
Eck et al (Gene-Based Therapy, In: The Pharmacological Basis of Therapeutics, Goodman and Gilman, Ed.s, 1996, pp. 77-10.
Orkin et al ( “Report and Recommendation of the Panel to Assess the NIH Investment in Research on Gene Therapy”, NIH, 1995).
Houdebine, Journal of Biotechnology, 1994, vol. 34, pp. 269-287.
Sundarraj et al (FEBS Letters, 1978, vol. 85, pp. 47-51).
Abstract of Crawford and Black, (Virology, 1964, vol. 24, pp. 388-392).
Graessman and Graessman, (‘The Transformation Capacity of Early SV40 Fragments’, in: Cell Transformation, Celis and Graessman, Ed.s, 1984, pp. 113-126).
Varon et al (Cell, 1998, vol. 93, pp. 467-476).
Carney et al (Cell, 1998, vol. 93, pp. 477-486).
NCBI(AA577530), www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=nucleotide&list—uids= . . . , (1997),2.
NCBI(AA535711), www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=nucleotide&list—uids= . . . , (1997),2.
Allemand, I., et al., “Transgenic and Knock-Out Models for Studying DNA Repair”,Biochimie, 77, 826-832, (1995).
Baldwin, et al.,Monoclonal Antibodies for Cancer Detection and Therapy, 20, (1985).
Brandon, E.P., et al., “Targeting the Mouse Genome: A Compendium of Knockouts (Part I)”,Current Biology, 5, 625-634, (1995).
Brandon, E.P., et al., “Targeting the Mouse Genome: A Compendium of Knockouts (Part II)”,Current Biology, 5, 758-765, (1995).
Choi, I.S., et al., “Expression of RAD4 gene ofSaccharomyces cerevisiaethat can be propagated inEscherichia coliwithout inactivation”,Biochemical and Biophysical Research Communications, vol. 193 (1), 191-197, (May 28, 1993).
de Vries, Al., et al., “Xpa Knockout Mice”,Seminars in Cancer Biology, 7, 229-240, (1996).
Dolganov, G.M. et al., “Human Rad50 Is Physically Associated with Human Mrell: Identification of a Conserved Multiprotein Complex Implicated in Recombinational DNA Repair”,Molecular and Cellular Biology, 16, 4832-4841, (Sep. 1996).
Majzoub, J.A., et al., “Knockout Mice”,The New England Journal of Medicine, 334, 904-907, (Apr. 4, 1996).
Maser, R.S., et al., “hMrell and hRad50 Nuclear Foci Are Induced during the Normal Cellular Response to DNA Double-Strand Breaks”,Molecular and Cellular Biology, 17, 6087-6096, (Oct. 1997).
Nicolaides, N.C., et al., “Analysis of the 5′ region of PMS2 reveals heterogeneous transcripts and a novel overlapping gene”,Genomics, 29, 329-334, (1997).
Petrini, J.H., et al., “Isolation and characterizatio of the human MRE11 homologue”,Genomics, 29, 80-86, (1995).
Rosenberg, M.P., “Gene Knockout and Transgenic Technologies in Risk Assessment: The Next Generation”,Molecular Carcinogenesis, 20, 262-274, (1997).
Xiao, Y., et al., “Conditional gene targeted deletion by Cre recombinase demonstrates the requirement for the double-strand break repair Mrell protein in murine embryonic stem cells”,Nuclecid Acids Research, vol. 25, 15, 2985-2991, (1997).
Delange, T , et al., “A New Connection at Human Telomeres: Association of the Mrell Complex with TRF2”,Cold Spring Harbor Symposia on Quantitative Biology, Vol. LXV, Cold Spring Harbor Laborator Press,(Jun. 2001),265-273.
Lombard, D B., et al., “Nijmegen Breakage Syndrome Disease Protein and MRE11 at PML Nuclear Bodies and Meiotic Telomeres”,Cancer Res, 60, (May 1, 2000),2331-2334.
Wu, G. , et al., “NBS1 and TRF1 Colocalize at Promyelocytic Leukemia Bodies during Late S/G2 Phases in Immortalized Telomerase-negative”,The Journal of Biological Chemistry, 275 (39), (2000),30618-30622.
Zhu, X. , et al., “Cell-Cycle-Regulated Association of RAD50/MRE11/NBS1 with TRF2 and human Telomeres”,Nature Genetics, 25, (Jul. 2000),347-352.
Carney James Patrick
Maser Richard Scott
Morgan William Francis
Petrini John H. J.
Canella Karen A.
Schwegman Lundberg Woessner & Kluth P.A.
Wisconsin Alumni Research Foundation
LandOfFree
Methods to alter levels of a DNA repair protein does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods to alter levels of a DNA repair protein, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods to alter levels of a DNA repair protein will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3681728